David Linetsky - 13 Dec 2022 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role: SVP, Life Sciences
Signature: /s/ Allison Hoffman by Power of Attorney for David Linetsky
Issuer symbol: PHR
Transactions as of: 13 Dec 2022
Net transactions value: -$393,755
Form type: 4
Filing time: 15 Dec 2022, 15:54:49 UTC
Previous filing: 13 Dec 2022
Next filing: 20 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHR	Common Stock	Sale	$393,755	-11,377	-5.8%	$34.61	185,485	13 Dec 2022	Direct	F1, F2
holding	PHR	Common Stock						5,634	13 Dec 2022	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.